Despite guideline recommendations to the contrary, patients experiencing low back pain are commonly exposed to low-value care. Spinal injections for chronic low back pain are a key example of this disconnect. Their persistence highlights the broader challenge of removing low-value practices in pain care. Low-value interventions rarely fade with the introduction of new treatments; rather, their continued use reflects entrenched reimbursement incentives, provider training norms, and patient expectations. This Focus Article applies implementation science concepts to examine spinal injections as an obvious candidate for de-implementation away from existing practice patterns. Evidence of limited effectiveness and risks is summarized, alongside multilevel determinants that sustain ongoing use at the provider, patient, organizational, and system levels. A range of strategies is mapped to guide change and a four-step roadmap is presented to operationalize these concepts. Embedding de-implementation of spinal injections alongside implementation efforts for other pain management options reframes change as an intentional redesign of care delivery rather than a withdrawal of treatment. By redirecting resources away from ineffective procedures and toward evidence-based alternatives, de-implementation offers a proactive pathway to improve outcomes, enhance equity, reduce waste, and strengthen patient trust in pain management. PERSPECTIVE: This article applies an implementation science lens to spinal injections for chronic low back pain. By outlining barriers, strategies, and describing a practical roadmap, it reframes de-implementation as a proactive quality improvement approach that offers other viable treatment options while redirecting resources towards higher value treatment options for pain management.
Ballengee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: